This isn't about whistleblowers [BE/BA News]

posted by Dr_Dan  – Germany, 2017-05-24 21:06 (2819 d 03:55 ago) – Posting: # 17407
Views: 5,254

❝ this isn't so much about whistleblowing. It is about defining a type of deviations that require expedited reporting (analogous to SAE's) and defining who is supposed to do what and when.


IMHO the message of this guideline is fatal: EMA is not will to spent effort in the surveillance of clinical studies and has not the intellectual and personal capacities to do so. Why should the Sponsor provide the arguments which will be used to reject his study? The people who prepared this guideline live behind the moon.
Dear car driver, report any contempt against red lights and tempo Limits to your authority so that your licence can be invalidated. hahaha

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,379 posts in 4,913 threads, 1,661 registered users;
104 visitors (0 registered, 104 guests [including 20 identified bots]).
Forum time: 00:01 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5